BackKKALSHI

When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List? (Before November)

Yes 7.5%

Vol32.6K contracts

SnapshotOct 29, 2026, 12:00 AM UTC

Yes 7.5%

TradeTrade on Kalshi

Event

MarketKALSHIactive

MarketKALSHIactiveHealth

When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List? (Before November)

Part of: When will the FDA reclassify BPC-157 to Category 1?

YesYes Price

7.5¢

VolTotal Volume

32.6K contracts

Outcomes

Ends

Nov 8, 2026, 3:00 PM UTC

Trade on Kalshi

When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List? (Before November)

Yes

7.5¢

Vol

32.6K contracts

Outcomes

Trade

Yes7.5¢

No92.5¢

Outcome

Yes quoted price: 7.5%. Snapshot Oct 29, 2026, 12:00 AM UTC. History may have a different observation time.

Price History

When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List? (Before November) · Yes

No historical data available

Price history will appear here when available

Rules and settlement

Listed close: Nov 8, 2026, 3:00 PM UTC. Settlement follows the provider's contract terms and may occur later.

If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Nov 1, 2026, then the market resolves to Yes. Secondary rules: The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility. Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion. Early close condition: This market will close and expire early if the event occurs.

Read this contract on Kalshi

Resolution Info